InvestorsHub Logo
Followers 827
Posts 119468
Boards Moderated 15
Alias Born 09/05/2002

Re: DewDiligence post# 314

Thursday, 04/02/2020 11:07:42 AM

Thursday, April 02, 2020 11:07:42 AM

Post# of 866
MRK’s KEYNOTE-177 succeeds in 1L-MSI-H/dMMR CRC, which should enable MRK’s 2017 FDA accelerated approval (#msg-131597556) to be converted to a full FDA approval:

https://www.mrknewsroom.com/news-release/oncology/merck-announces-keytruda-pembrolizumab-significantly-improved-progression-free

The primary endpoint of KEYNOTE-177 was PFS.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent MRK News